» Articles » PMID: 11877420

Tyrosine Phosphorylation of the Beta-amyloid Precursor Protein Cytoplasmic Tail Promotes Interaction with Shc

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Mar 6
PMID 11877420
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

beta-Amyloid precursor protein (APP) is a widely expressed transmembrane protein of unknown function that is involved in the pathogenesis of Alzheimer's disease. The cytoplasmic tail of APP interacts with phosphotyrosine binding (PTB) domain containing proteins (Fe65, X11, mDab-1, and JIP-1) and may modulate gene expression and apoptosis. We now identify Shc A and Shc C, PTB-containing adapter proteins that signal to cellular differentiation and survival pathways, as novel APP-interacting proteins. The APP cytoplasmic tail contains a PTB-binding motif (Y(682)ENPTY(687)) that, when phosphorylated on Tyr(682), precipitated the PTB domain of Shc A and Shc C, as well as endogenous full-length Shc A. APP and Shc C were physically associated in adult mouse brain homogenates. Increase in phosphorylation of APP by overexpression of the nerve growth factor receptor Trk A in 293T cells promoted the interaction of transfected APP and endogenous Shc A. Pervanadate treatment of N2a neuroblastoma cells resulted in tyrosine phosphorylation and association of endogenous APP and Shc A. Thus, APP and Shc proteins interact in vitro, in cells, and in the mouse brain. Tyrosine phosphorylation of APP may promote the interaction with Shc proteins.

Citing Articles

Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.

Volloch V, Rits-Volloch S Genes (Basel). 2025; 16(1.

PMID: 39858593 PMC: 11764795. DOI: 10.3390/genes16010046.


Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(18).

PMID: 39337400 PMC: 11432332. DOI: 10.3390/ijms25189913.


Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations.

Wang J, Fourriere L, Gleeson P Biochem J. 2024; 481(19):1297-1325.

PMID: 39302110 PMC: 11555708. DOI: 10.1042/BCJ20240056.


ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(11).

PMID: 38892224 PMC: 11172602. DOI: 10.3390/ijms25116036.


On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(5).

PMID: 38474228 PMC: 10932000. DOI: 10.3390/ijms25052981.